Finance
TRIPP PsyAssist will provide protocols and anxiety-easing support to patients undergoing ketamine-assisted therapy.
The survey results were based on responses from nearly 400 chief financial officers and revenue cycle leaders at health systems and hospitals across the United States.
The company has $6 million in seed funding from Lightspeed Venture Partners, Define Ventures and Qiming Venture Partners USA.
The funds will be used for product development and building customer-facing teams.
The acquisition will enable Verily to build out its clinical trial platform, Baseline, which houses technology for decentralized and hybrid trials.
The acquisition will result in the integration of ConsenSys Health’s Elevated Compute platform with technology components that underpin the FHIRBlocks Consent4Health application.
Unite Us said the acquisition will help organizations address health inequities and create new care models.
The funds raised will be used for geographical expansion and to improve their biomarker technology.
The digital health platform moves into the home health space with the $65 million acquisition.
Labcorp did not disclose the terms of the deal, but said this acquisition will be another step into the growing femtech market.